Key summary points
To evaluate the health-related quality of life (HR-QoL) trajectory during the first year after cancer treatment in patients with resectable primary colon cancer.
AbstractSection FindingsOn average, HR-QoL recovered to baseline level one year after start of treatment. However, 1 out of 7 patients, particularly older patients who received adjuvant chemotherapy, were at risk of non-resilience or a late decline in HR-QoL.
AbstractSection MessageOur findings provide insight in risks for a permanent loss of HR-QoL which may support patients and physicians in the treatment decision-making process to optimize tailored cancer care.
Abstract
Purpose
This study aims to evaluate quality of life trajectory during the first year after surgical treatment in patients with resectable primary colon cancer.
Methods
Patients with resectable primary colon cancer diagnosed between 2013 and 2019 who received surgical treatment and adjuvant chemotherapy if indicated were selected from the Prospective Dutch ColoRectal Cancer cohort study (PLCRC). Health-related quality of life (HR-QoL) was assessed using EORTC-QLQ-C30 questionnaire before surgery, and three and twelve months after surgery. HR-QoL scores varied between 0 and 100 and outcomes were compared according to age (< 70 years, ≥ 70 years), comorbidity (yes, no) and treatment type (adjuvant chemotherapy, surgical treatment only). The extent of resilience, defined as a recovery of HR-QoL to baseline level after a clinically relevant decline in HR-QoL at months, was calculated twelve months post-surgery.
Results
For all 458 patients, the mean age was 66.4 years (SD 9.5), 40% were aged 70 years and older and 68% were men. Baseline level of HR-QoL summary score was relatively high with a mean of 87.9 (SD 11.5), and did not significantly differ between older and younger patients. The strongest decline of HR-QoL compared to baseline was observed at three months with a gradual recovery over time. Fourteen percent of all patients were non-resilient or showed a late decline at twelve months post-surgery. Compared to younger patients, older patients who received adjuvant chemotherapy were less resilient (respectively, 53 and 32%, p = 0.07) and at risk of a late decline in HR-QoL 1 year post-surgery (respectively, 3% versus 16%, p = 0.02). Comorbidity status had no significant impact on the HR-QoL trajectory.
Conclusion
Colon cancer treatment was associated with a decline in HR-QoL three months post-surgery, but most patients return to baseline level within twelve months. Still, particularly older patients who received adjuvant chemotherapy were less resilient and at risk of a late decline in HR-QoL. These data could help in patients counselling regarding colon cancer treatment.
Similar content being viewed by others
Data availability
Netherlands Comprehensive Cancer Organisation (IKNL) and Prospective Dutch ColoRectal Cancer cohort (PLCRC).
Change history
03 May 2023
A Correction to this paper has been published: https://doi.org/10.1007/s41999-023-00782-1
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
Institute NC. Cancer Stat Facts [Internet]. [cited 2019 Jul 21]. Available from: https://seer.cancer.gov
Kankerregistratie N. Cijfers over kanker [Internet]. [cited 2019 Oct 2]. Available from: https://www.cijfersoverkanker.nl/
Federatie Medisch specialisten. Colorectal Cancer Dutch Guideline Oncoline version 3.0 [Internet]. 2014. Available from: https://www.nhg.org/sites/default/files/content/nhg_org/uploads/colorectaalcarcinoom.pdf
Scher KS, Hurria A (2012) Under-representation of older adults in cancer registration trials: known problem, little progress. J Clin Oncol 30(17):2036–2038
Hurria A, Mohile SG, Dale W (2012) Research priorities in geriatric oncology: addressing the needs of an aging population. JNCCN J Natl Compr Cancer Netw 10(2):286–288
Hamaker ME, Prins MC, Schiphorst AH, van Tuyl SAC, Pronk A, van den Bos F (2015) Long-term changes in physical capacity after colorectal cancer treatment. J Geriatr Oncol 6:153–164
Couwenberg AM, Burbach JPM, van Grevenstein WMU, Smits AB, Consten ECJ, Schiphorst AHW et al (2018) Effect of neoadjuvant therapy and rectal surgery on health-related quality of life in patients with rectal cancer during the first 2 years after diagnosis. Clin Colorectal Cancer 17(3):500–512
Montroni I, Ugolini G, Saur NM, Rostoft S, Antonino Spinelli BLVL (2022) Quality of life in older adults after major cancer surgery: the GOSAFE international study. J Natl Cancer Inst 114(7):969–978
Bours MJL, Linden BWA, Winkels RM, Duijnhoven FJ, Mols F, Roekel EH et al (2016) Candidate predictors of health-related quality of life of colorectal cancer survivors: a systematic review. Oncologist 21:433–452
Cummings A, Grimmett C, Calman L, Patel M, Permyakova NV, Winter J et al (2018) Comorbidities are associated with poorer quality of life and functioning and worse symptoms in the 5 years following colorectal cancer surgery: Results from the ColoREctal Well-being (CREW) cohort study. Psychooncology 27(10):2427–2435
Wheelwright S, Permyakova NV, Calman L, Din A, Fenlon D, Richardson A et al (2020) Does quality of life return to pre-treatment levels 5 years after curative intent surgery for colorectal cancer? Evidence from the ColoREctal Wellbeing (CREW) study. PLoS ONE 15(4):e0231332
van der Vlies E, Vernooij LM, Hamaker ME, van der Velden AMT, Smits M, Intven MPW et al (2022) Frailty and health related quality of life three months after non-metastatic colorectal cancer diagnosis in older patients: a multi-centre prospective observational study. J Geriatr Oncol 13(1):74–81
Tamura S, Suzuki K, Ito Y, Fukawa A (2021) Factors related to the resilience and mental health of adult cancer patients: a systematic review. Support Care Cancer 29(7):3471–3486
Gijzel SMW, Whitson HE, van de Leemput IA, Scheffer M, van Asselt D, Rector JL et al (2019) Resilience in clinical care: getting a grip on the recovery potential of older adults. J Am Geriatr Soc 67(12):2650–2657
Seiler A, Jenewein J (2019) Resilience in cancer patients. Front Psychiatry. https://doi.org/10.3389/fpsyt.2019.00208
Scheepers ERM, Vink GR, Schiphorst AHW, Emmelot-Vonk MH, van Huis-Tanja LH, Hamake ME (2022) The impact of surgery and adjuvant chemotherapy on health-related quality of life in patients with colon cancer: changes at group-level versus individual-level. Eur J Cancer Care 31(6):e13691
Burbach JPM, Kurk SA, van Coeberghden Braak RRJ, Dik VK, May AM, Meijer GA et al (2016) Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research. Acta Oncol (Madr). 55(11):1273–1280
Integraal Kankercentrum Nederland (IKNL). Cijfers over Kanker [Internet]. [cited 2020 Jan 6]. Available from: https://www.iknl.nl/nkr-cijfers
NVVH. Colorectaal Carcinoom [Internet]. 2019 [cited 2021 Jun 4]. Available from: https://richtlijnendatabase.nl/richtlijn/colorectaal_carcinoom_crc/startpagina_-_crc.html
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL TA. AJCC Cancer Staging Manual 7th edition [Internet]. 2010. Available from: http://cancerstaging.org/references-tools/deskreferences/Documents/AJCC 7th Ed Cancer Staging Manual.pdf
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376
Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) on behalf of the EORTC quality of lifr group. The EORTIC QLQ-C30 scoring manual (3rd Edition). Europen Organization for Research and Treatment of cancer, Brussels
Giesinger JM, Kieffer JM, Fayers PM, Groenvold M, Petersen MA, Scott NW et al (2016) Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol 69:79–88
Cocks K, King MT, Velikova G, St-James MM, Fayers PM, Brown JM (2011) Evidence-based guidelines for determination of sample size and interpretation of the European organisation for the research and treatment of cancer quality of life questionnaire core 30. J Clin Oncol 29(1):89–96
Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life. Med Care 41(5):582–592
Cabilan CJ, Hines S (2017) The short-term impact of colorectal cancer treatment on physical activity, functional status and quality of life: a systematic review. JBI Database Syst Rev Implement Rep 15(2):517–566
Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MAG, Fayers PM (2006) The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual Life Res 15(9):1533–1550
Fried TR, Bradley EH, Towle VR, Allore H (2002) Understanding the treatment preferences of seriously Ill patients. N Engl J Med 346(14):1061–1065
Wildiers H, Mauer M, Pallis A, Hurria A, Mohile SG, Luciani A et al (2013) End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer-alliance for clinical trials in oncology-international society of geriatric oncology position article. J Clin Oncol 31(29):3711–3718
Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA et al (2016) Updating the American society of clinical oncology value framework: revisions and reflections in response to comments received. J Clin Oncol 34(24):2925–2934
Scheepers ERM, van Huis-Tanja LH, Emmelot-Vonk MH, Hamaker ME (2021) Study objectives in clinical trials in older patients with solid malignancies: do we measure what matters? Qual Life Res 30(7):1833–1839
Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S et al (2005) Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International society of geriatric oncology (SIOG). Crit Rev Oncol Hematol 55(3):241–325
MacLeod S, Musich S, Hawkins K, Alsgaard K, Wicker ER (2016) The impact of resilience among older adults. Geriatr Nurs (Minneap) 37:266–272
Acknowledgements
The authors would like to thank the registration team of Netherlands Comprehensive Cancer Organisation (IKNL) and investigators of the Prospective Dutch ColoRectal Cancer cohort for the collection of data.
Funding
Dr. Vink reports grants from Servier, grants from BMS, grants from Merck, grants from Sirtex, grants from Bayer, grants from PGDx, from Pierre-Fabre, outside the submitted work; all other authors have nothing to disclose.
Author information
Authors and Affiliations
Contributions
ES: study design, data analysis, writing, and tables/figures. GV: writing and approval of final document. AS: writing and approval of final document. ME: writing and approval of final document. LH: writing and approval of final document. MH: study design, writing, and approval of final document.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declared that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research commitee and with the 1964 Helsinki declaration and its amendments or comparable ethical standards.
Informed consent
All patients provided informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: plus the same explanatory text of the problem as in the erratum/correction article.
Supplementary Information
Below is the link to the electronic supplementary material.
41999_2023_750_MOESM2_ESM.docx
Supplementary data Table S1. Clinically relevant differences of HR-QoL at twelve months compared to baseline level, stratified by age. (docx 16 KB)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Scheepers, E.R.M., Vink, G.R., Schiphorst, A.H.W. et al. Health-related quality-of-life trajectories during/after surgery and adjuvant chemotherapy in patients with colon cancer. Eur Geriatr Med 14, 565–572 (2023). https://doi.org/10.1007/s41999-023-00750-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41999-023-00750-9